stars 1 stars 2 stars 3

Medannex is an award-winning Scottish biopharmaceutical company committed to unlocking the therapeutic potential of targeting annexin-A1. Our goal is to create a first-in-class therapy to improve the lives of people impacted by cancers and autoimmune diseases. Following a recent Series B fundraise, and supported by both the Scottish Investment Bank and Innovate UK, Medannex is collaborating with world-leading clinical experts to explore the huge therapeutic and commercial potential of our patent-protected immunomodulatory technology.

View Top Employees from Medannex Ltd
Website http://medannex.org/
Employees 11 (11 on RocketReach)
Founded 2009
Phone +44 131 357 4251
Technologies
Industry Biotechnology Research, Business Services General, Biotechnology, Business Services, Science and Engineering, Clinical Trials, Health Care
SIC SIC Code 87 Companies, SIC Code 873 Companies
NAICS NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 541713 Companies

Medannex Ltd Questions

Ian Abercrombie is the CEO of Medannex Ltd.

11 people are employed at Medannex Ltd.

The NAICS codes for Medannex Ltd are [54171, 541, 5417, 54, 541713].

The SIC codes for Medannex Ltd are [87, 873].

Top Medannex Ltd Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users